E. coli Cell Banking

• Protecting Your E. coli Strains with Cell Banking

  So scientists can design larger or less dangerous experiments safe in the knowledge their bacteria are shielded as they carry out their work. Who Go For It: This release candidate is going to be helpful for Visual C++ developers inside binging their labs and bar tastiest. 

  
  

• Streamlining Your Research with E. coli Cell Banking Services

  Scientists using Yaohai's services could save not only time, but money. At least they don't have to "purchase" new E. coli every time: Instead, they can use the E. coli that they banked. This is not just costly, however it also assists them to conserve important resources. 

  
  

• Maximizing Efficiency in Your Lab with E. coli Cell Banking

  Additionally, it is true for all the EST libraries (~35), that they used the same type of E. coli. This keeps results uniform from each and dependable and reproducible. Standardization in this way means that if researchers report new findings, their scientific peers can rely on them as a benchmark. 

   

  
  

Why choose Yaohai E. coli Cell Banking?

• Professional Expertise & Extensive Experience

  Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our primary focus is the production of microbial vaccinations and therapeutics for managing pets, human and E. coli Cell Banking. We are equipped with cutting-edge RD platforms as well as manufacturing technologies that encompass the entire process beginning with the development of microbial strains and cell banking, to method and process development, to clinical and commercial manufacture that ensures the successful supply of new solutions. Through the years, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed and we assist our clients to get through regulations, such as those of the US FDA and EU EMA. We also assist them in navigating Australia TGA and China NMPA. We are able respond promptly to market demands and offer tailored CDMO services thanks to our experience and expertise.

• Robust Supply Chain & Manufacturing Capabilities

  E. coli Cell Banking is a Top 10 biotech company specializing in microbiological fermentation. We have built a modern facility with strong RD capabilities and modern manufacturing facilities. Five production lines for pharmaceuticals in line with GMP standards for microbial purification and fermentation along with two automated fill and finish lines for vials and cartridges and pre-filled needles are available. The fermentation scales available are 100L, 500L, 1000L, to 2000L. Specifications for filling vials range from 1ml up to 25ml. the pre-filled syringes and cartridge filling specifications cover between 1-3ml. The workshop for production is cGMP compliant, and guarantees a stable supply of commercial products and clinical samples. Our factory produces large molecules that are shipped around the world.

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality management and regulatory issues. We have developed a solid quality management system that conforms to the current GMP standards and regulations globally. Our regulatory team has an in-depth understanding of the world-wide regulatory frameworks. This allows us to accelerate biological launches. We ensure traceable production processes as well as high-quality products and in compliance with the guidelines of the US FDA and EU EMA. E. coli Cell Banking and China NMPA are also satisfied. Yaohai BioPharma successfully passed an on-site audit conducted by an accredited Qualified Person of the European Union (QP) to review our GMP system and production facility. We have also been through the first certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as E. coli Cell Banking of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

Related product categories

• E. coli Cell Bank Characterization
• E. coli Cell Bank Preparation
• E. coli Cell Bank Testing
• E. coli Cell Banking

Not finding what you're looking for?
Contact our consultants for more available products.